{"id":"https://openalex.org/W4362542947","doi":"https://doi.org/10.1158/1538-7445.am2023-2812","title":"Abstract 2812: NL-201, a de novo CD25-independent IL-2R\u03b2\u03b3 agonist, synergizes with radiation to generate potent antitumor immunity","display_name":"Abstract 2812: NL-201, a de novo CD25-independent IL-2R\u03b2\u03b3 agonist, synergizes with radiation to generate potent antitumor immunity","publication_year":2023,"publication_date":"2023-04-04","ids":{"openalex":"https://openalex.org/W4362542947","doi":"https://doi.org/10.1158/1538-7445.am2023-2812"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2023-2812","doi":"https://doi.org/10.1158/1538-7445.am2023-2812","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2023-2812","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087286844","display_name":"Kristin Michelle Huntoon","orcid":"https://orcid.org/0000-0002-7211-8986","observed_orcids":["https://orcid.org/0000-0002-7211-8986"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kristin Huntoon","raw_affiliation_strings":["1UT MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078626693","display_name":"DaeYong Lee","orcid":"https://orcid.org/0000-0001-8485-3577","observed_orcids":["https://orcid.org/0000-0001-8485-3577"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"DaeYong Lee","raw_affiliation_strings":["1UT MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100400529","display_name":"Xuefeng Li","orcid":"https://orcid.org/0000-0001-8146-8374","observed_orcids":["https://orcid.org/0000-0001-8146-8374","https://orcid.org/0000-0003-1839-9198"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xuefeng Li","raw_affiliation_strings":["1UT MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100398535","display_name":"Yifan Wang","orcid":"https://orcid.org/0000-0001-7387-0654","observed_orcids":["https://orcid.org/0000-0001-7387-0654"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yifan Wang","raw_affiliation_strings":["1UT MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090210760","display_name":"Wen Jiang","orcid":"https://orcid.org/0000-0001-9154-633X","observed_orcids":["https://orcid.org/0000-0001-9154-633X","https://orcid.org/0000-0003-0612-2917","https://orcid.org/0000-0002-6073-3260","https://orcid.org/0000-0001-6858-2666"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wen Jiang","raw_affiliation_strings":["1UT MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5017997501","display_name":"Betty Y.S. Kim","orcid":"https://orcid.org/0000-0001-6890-8355","observed_orcids":["https://orcid.org/0000-0001-6890-8355"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Betty Kim","raw_affiliation_strings":["1UT MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"83","issue":"7_Supplement","first_page":"2812","last_page":"2812"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.5429999828338623,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.5429999828338623,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.38769999146461487,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11668","display_name":"interferon and immune responses","score":0.043699998408555984,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/radiotherapy","display_name":"radiotherapy","score":0.6190000176429749},{"id":"https://openalex.org/keywords/radioimmunotherapy","display_name":"radioimmunotherapy","score":0.7549999952316284},{"id":"https://openalex.org/keywords/cgas-sting-pathway","display_name":"cGAS-STING pathway","score":0.8809999823570251},{"id":"https://openalex.org/keywords/type-i-interferon","display_name":"type I interferon","score":0.9539999961853027},{"id":"https://openalex.org/keywords/tumor-associated-dendritic-cells","display_name":"tumor-associated dendritic cells","score":0.8460000157356262},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.6710000038146973},{"id":"https://openalex.org/keywords/pd-1-inhibitors","display_name":"PD-1 inhibitors","score":0.6740000247955322},{"id":"https://openalex.org/keywords/4t1-breast-tumor","display_name":"4T1 breast tumor","score":0.8629999756813049}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6253013610839844},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.605698823928833},{"id":"https://openalex.org/C79484868","wikidata":"https://www.wikidata.org/wiki/Q5971673","display_name":"IL-2 receptor","level":4,"score":0.5851280093193054},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.5303010940551758},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.5217108130455017},{"id":"https://openalex.org/C2777371288","wikidata":"https://www.wikidata.org/wiki/Q410130","display_name":"Interleukin 2","level":3,"score":0.46649643778800964},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.4395826458930969},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.4383270740509033},{"id":"https://openalex.org/C2777349159","wikidata":"https://www.wikidata.org/wiki/Q18055374","display_name":"Stimulator of interferon genes","level":4,"score":0.42920833826065063},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.4186205565929413},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4060762822628021},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3908997178077698},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.3902423083782196},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3764534294605255},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.35986971855163574},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.28574204444885254},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.21503955125808716},{"id":"https://openalex.org/C136449434","wikidata":"https://www.wikidata.org/wiki/Q428253","display_name":"Innate immune system","level":3,"score":0.15044641494750977}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2023-2812","doi":"https://doi.org/10.1158/1538-7445.am2023-2812","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2023-2812","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4282976356","https://openalex.org/W4388621393","https://openalex.org/W4309014058","https://openalex.org/W3104437666","https://openalex.org/W4386897790","https://openalex.org/W3216600142","https://openalex.org/W4410319687","https://openalex.org/W4391379267","https://openalex.org/W4367668420","https://openalex.org/W4385639022"],"abstract_inverted_index":{"Abstract":[0],"There":[1],"is":[2,19,54],"a":[3,104,397,425],"growing":[4],"interest":[5],"in":[6,21,100,130,242,305,326,390],"combining":[7],"radiotherapy":[8],"(RT)":[9],"with":[10,23,102,115,125,132,143,167,198,203,237,245,253,263,292,360,392,432],"immunotherapeutic":[11],"agents":[12],"to":[13,214,233,271,377,399,405,434],"improve":[14],"efficacy.":[15],"One":[16],"such":[17],"approach":[18],"RT":[20,99,133,230,315,389],"combination":[22,101,131,205,228,256,328,364,391],"high-dose":[24,51],"recombinant":[25,52],"interleukin":[26],"2":[27],"(IL-2),":[28],"which":[29,351],"elicits":[30],"anti-tumor":[31,96,355],"immune":[32,324,330,403],"responses":[33],"by":[34,56,70],"stimulating":[35],"T-cell":[36,267],"and":[37,58,95,107,111,120,154,177,183,190,201,210,231,260,286,314,332,346,455],"NK":[38],"cell":[39],"populations.":[40],"Although":[41],"effective":[42],"for":[43,118,354,384,446],"some":[44],"patients,":[45],"the":[46,59,76,137,204,224,227,254,283,296,309,312,319,327,340,385,401,443],"overall":[47],"clinical":[48],"benefit":[49],"of":[50,61,83,89,98,136,156,226,229,299,303,311,322,343,349,369,388,442],"IL-2":[53,110,285],"limited":[55],"toxicity":[57],"expansion":[60],"regulatory":[62],"T":[63],"cells":[64,160],"(Tregs)":[65],"through":[66],"signaling":[67],"events":[68],"mediated":[69],"IL2R\u03b1":[71],"(CD25).":[72],"Here":[73],"we":[74,222],"examined":[75],"cytosolic":[77],"DNA":[78],"sensor":[79],"cyclic":[80],"GMP-AMP":[81],"synthase-stimulator":[82],"interferon":[84,92],"genes":[85],"(cGAS-STING)":[86],"pathway":[87],"dependency":[88],"type":[90,145],"I":[91,146,171],"(IFN)":[93],"response":[94,404],"effect":[97],"NL-201,":[103,290,424],"highly":[105],"potent":[106,436],"stable":[108],"CD25-independent":[109,284,393,428],"IL-15":[112,287],"receptor":[113,288],"agonist":[114],"enhanced":[116,134],"affinity":[117],"IL2R\u03b2":[119],"IL2R\u03b3c.":[121],"In":[122,162],"mice":[123,165,196,243,251,307],"implanted":[124,166,197,244],"E0771":[126,168,199],"syngeneic":[127],"tumors,":[128,169],"NL-201":[129,232,313],"activation":[135,153,298,331,345],"STING":[138,163,304],"pathway.":[139],"This":[140,380],"was":[141,180],"associated":[142,158],"increased":[144,152,264],"IFN":[147,172,211],"production":[148,212],"as":[149,151,269,396],"well":[150],"number":[155],"tumor":[157,248,347],"dendritic":[159],"(DCs).":[161],"(-/-)":[164],"Type":[170],"production,":[173],"tumor-growth":[174],"inhibition":[175],"(TGI),":[176],"survival":[178],"advantage":[179],"significantly":[181,186,366],"decreased":[182],"there":[184],"were":[185,352,374],"fewer":[187],"activated":[188],"CD4+":[189],"CD8+":[191],"T-cells.":[192],"Similarly,":[193],"CD11c+":[194],"knock-out":[195],"tumors":[200],"treated":[202,216,252],"exhibited":[206,257],"similar":[207],"TGI,":[208],"survival,":[209,261],"compared":[213,270],"vehicle":[215],"mice.":[217],"Based":[218],"on":[219],"these":[220],"results,":[221],"tested":[223],"ability":[225],"enhance":[234,400],"systemic":[235,402],"immunotherapy":[236],"an":[238],"anti-PD-1":[239,361],"checkpoint":[240,378],"inhibitor":[241],"4T1":[246],"breast":[247,371],"cells.":[249],"Tumor-bearing":[250],"triple":[255],"superior":[258],"TGI":[259,368],"along":[262],"effector":[265],"memory":[266],"populations":[268],"all":[272],"other":[273],"treatment":[274,365],"groups.":[275],"These":[276,336],"results":[277,337],"support":[278],"our":[279],"previous":[280],"findings":[281],"that":[282,373],"agonist,":[289,430],"synergizes":[291,431],"RT,":[293],"likely":[294],"via":[295],"direct":[297],"STING.":[300],"Genetic":[301],"knockout":[302],"tumor-bearing":[306],"abrogated":[308],"activity":[310],"combination,":[316],"thus":[317],"confirming":[318],"crucial":[320,353],"role":[321,342],"innate":[323],"sensors":[325],"treatment\u2019s":[329],"resulting":[333],"antitumor":[334,437],"effect.":[335],"also":[338],"describe":[339],"important":[341],"STING-mediated":[344],"penetration":[348],"DCs,":[350],"response.":[356],"Additionally,":[357],"when":[358],"combined":[359],"antibodies,":[362],"NL-201+RT":[363],"improved":[367],"metastatic":[370],"cancers":[372],"previously":[375],"resistant":[376],"blockade.":[379],"work":[381],"provides":[382],"rationale":[383],"continued":[386],"exploration":[387],"IL-2R\u03b2\u03b3":[394,429],"agonism":[395],"means":[398],"treat":[406],"immunologically":[407],"challenging":[408],"tumors.":[409],"Citation":[410],"Format:":[411],"Kristin":[412],"Huntoon,":[413],"DaeYong":[414],"Lee,":[415],"Xuefeng":[416],"Li,":[417],"Yifan":[418],"Wang,":[419],"Wen":[420],"Jiang,":[421],"Betty":[422],"Kim.":[423],"de":[426],"novo":[427],"radiation":[433],"generate":[435],"immunity":[438],"[abstract].":[439],"In:":[440],"Proceedings":[441],"American":[444],"Association":[445],"Cancer":[447,466],"Research":[448],"Annual":[449],"Meeting":[450],"2023;":[451],"Part":[452],"1":[453],"(Regular":[454],"Invited":[456],"Abstracts);":[457],"2023":[458],"Apr":[459],"14-19;":[460],"Orlando,":[461],"FL.":[462],"Philadelphia":[463],"(PA):":[464],"AACR;":[465],"Res":[467],"2023;83(7_Suppl):Abstract":[468],"nr":[469],"2812.":[470]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2023-04-06T00:00:00"}